Literature DB >> 9039541

Prevalence of anti-HCV antibodies in chronic liver disease in the Czech Republic.

J Stránský, M Horejsová, A Chlumská, E Honzáková, J Vandasová, V Nĕmecek.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9039541     DOI： 10.1007/bf02113511

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  8 in total

1.  The significance of antibody to hepatitis C virus in patients with chronic hepatitis B.

Authors:  T L Fong; A M Di Bisceglie; J G Waggoner; S M Banks; J H Hoofnagle
Journal:  Hepatology       Date:  1991-07       Impact factor: 17.425

2.  Clinical importance of assessment of anti-HCV IgM antibodies in chronic hepatitis C.

Authors:  J Stránský; E Honzáková; J Vandasová; M Horejsová; J Kyncl; V Nĕmecek; J Horák
Journal:  Acta Virol       Date:  1996-04       Impact factor: 1.162

3.  Risk factors and predictors of outcome in an Australian cohort with hepatitis C virus infection.

Authors:  S I Strasser; K J Watson; C S Lee; P J Coghlan; P V Desmond
Journal:  Med J Aust       Date:  1995-04-03       Impact factor: 7.738

4.  Prevalence and significance of hepatitis C viremia in chronic active hepatitis B.

Authors:  J Crespo; J L Lozano; F de la Cruz; L Rodrigo; M Rodríguez; G San Miguel; E Artiñano; F Pons-Romero
Journal:  Am J Gastroenterol       Date:  1994-08       Impact factor: 10.864

5.  Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: high percentage of carriers of hepatitis B and C virus.

Authors:  W Jilg; E Sieger; R Zachoval; H Schätzl
Journal:  J Hepatol       Date:  1995-07       Impact factor: 25.083

6.  Displacement of hepatitis B virus by hepatitis C virus as the cause of continuing chronic hepatitis.

Authors:  Y F Liaw; S L Tsai; J J Chang; I S Sheen; R N Chien; D Y Lin; C M Chu
Journal:  Gastroenterology       Date:  1994-04       Impact factor: 22.682

Review 7.  The interaction between hepatitis B virus and hepatitis C virus in acute and chronic liver disease.

Authors:  A Alberti; P Pontisso; L Chemello; G Fattovich; L Benvegnù; F Belussi; M S De Mitri
Journal:  J Hepatol       Date:  1995       Impact factor: 25.083

8.  Cellular immune responses in patients with dual infection of hepatitis B and C viruses: dominant role of hepatitis C virus.

Authors:  S L Tsai; Y F Liaw; C T Yeh; C M Chu; G C Kuo
Journal:  Hepatology       Date:  1995-04       Impact factor: 17.425
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.